| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024236179 |
| P356 | DOI | 10.1186/1471-2407-14-758 |
| P932 | PMC publication ID | 4198707 |
| P698 | PubMed publication ID | 25305067 |
| P5875 | ResearchGate publication ID | 266745192 |
| P50 | author | Johannes Giesinger | Q48077994 |
| Lisa M Wintner | Q56992279 | ||
| P2093 | author name string | Bernhard Holzner | |
| Georg Kemmler | |||
| August Zabernigg | |||
| Eva-Maria Gamper | |||
| Anne S Oberguggenberger | |||
| Monika J Sztankay | |||
| P2860 | cites work | Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance | Q29615569 |
| The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 | ||
| Measuring health-related quality of life in adolescents and young adults: Swedish normative data for the SF-36 and the HADS, and the influence of age, gender, and method of administration | Q33265236 | ||
| The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring | Q34472415 | ||
| Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study | Q34626554 | ||
| Quality of life scores differed according to mode of administration in a review of three major oncology questionnaires | Q36373797 | ||
| Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients | Q36474893 | ||
| A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery | Q36810351 | ||
| Effects of mode and order of administration on generic health-related quality of life scores | Q37395480 | ||
| Development, feasibility and compliance of a web-based system for very frequent QOL and symptom home self-assessment after hematopoietic stem cell transplantation. | Q40435631 | ||
| Timing of quality of life (QoL) assessments as a source of error in oncological trials | Q43724371 | ||
| Patient online self-reporting of toxicity symptoms during chemotherapy | Q48950499 | ||
| A clinical model for quality of life assessment in cancer patients receiving chemotherapy. | Q53528875 | ||
| Effects of altering the time of administration and the time frame of quality of life assessments in clinical trials: an example using the EORTC QLQ-C30 in a large anti-emetic trial. | Q53578107 | ||
| Interpreting the significance of changes in health-related quality-of-life scores. | Q53584979 | ||
| Interpreting clinically significant changes in patient-reported outcomes | Q58876704 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | quality of life | Q13100823 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 758 | |
| P577 | publication date | 2014-10-10 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Assessing quality of life on the day of chemotherapy administration underestimates patients' true symptom burden | |
| P478 | volume | 14 |
| Q41614364 | A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation. |
| Q92210637 | Astragalus polysaccharide (PG2) Ameliorates Cancer Symptom Clusters, as well as Improves Quality of Life in Patients with Metastatic Disease, through Modulation of the Inflammatory Cascade |
| Q36961779 | Factors that affect PERCIST-defined test-retest comparability: an exploration of feasibility in routine clinical practice |
| Q91752426 | Implementation of the Symptom Navi © Programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi© Pilot Study) |
| Q50935978 | Measurement of health-related quality of life during chemotherapy - the importance of timing. |
| Q36840009 | Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis |
| Q52573148 | Quality of life of patients with gastrointestinal cancers undergoing chemotherapy. |
| Q90248235 | Strategies to improve patient-reported outcome completion rates in longitudinal studies |
Search more.